CTLA4 and cancer: Chemotherapy and anti-CTLA-4 and/or anti-PD-(L)1 ICB combinations have been successful for many hard-to-treat cancers, such as mesothelioma,4 non-small cell lung cancer,5 breast cancer6 and colorectal cancer.7